These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27134162)

  • 41. Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia.
    Thol F; Damm F; Lüdeking A; Winschel C; Wagner K; Morgan M; Yun H; Göhring G; Schlegelberger B; Hoelzer D; Lübbert M; Kanz L; Fiedler W; Kirchner H; Heil G; Krauter J; Ganser A; Heuser M
    J Clin Oncol; 2011 Jul; 29(21):2889-96. PubMed ID: 21670448
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decreased DNA methylation in acute myeloid leukemia patients with DNMT3A mutations and prognostic implications of DNA methylation.
    Hájková H; Marková J; Haškovec C; Sárová I; Fuchs O; Kostečka A; Cetkovský P; Michalová K; Schwarz J
    Leuk Res; 2012 Sep; 36(9):1128-33. PubMed ID: 22749068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networks.
    Mallm JP; Iskar M; Ishaque N; Klett LC; Kugler SJ; Muino JM; Teif VB; Poos AM; Großmann S; Erdel F; Tavernari D; Koser SD; Schumacher S; Brors B; König R; Remondini D; Vingron M; Stilgenbauer S; Lichter P; Zapatka M; Mertens D; Rippe K
    Mol Syst Biol; 2019 May; 15(5):e8339. PubMed ID: 31118277
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutations in NOTCH1 PEST domain orchestrate CCL19-driven homing of chronic lymphocytic leukemia cells by modulating the tumor suppressor gene DUSP22.
    Arruga F; Gizdic B; Bologna C; Cignetto S; Buonincontri R; Serra S; Vaisitti T; Gizzi K; Vitale N; Garaffo G; Mereu E; Diop F; Neri F; Incarnato D; Coscia M; Allan J; Piva R; Oliviero S; Furman RR; Rossi D; Gaidano G; Deaglio S
    Leukemia; 2017 Sep; 31(9):1882-1893. PubMed ID: 28017968
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Capillary electrophoretic analysis of genomic DNA methylation levels.
    Stach D; Schmitz OJ; Stilgenbauer S; Benner A; Döhner H; Wiessler M; Lyko F
    Nucleic Acids Res; 2003 Jan; 31(2):E2. PubMed ID: 12527791
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Investigating epigenetic effects of activation-induced deaminase in chronic lymphocytic leukemia.
    Schubert M; Hackl H; Gassner FJ; Greil R; Geisberger R
    PLoS One; 2018; 13(12):e0208753. PubMed ID: 30571766
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD18 (ITGB2) expression in chronic lymphocytic leukaemia is regulated by DNA methylation-dependent and -independent mechanisms.
    Hutterer E; Asslaber D; Caldana C; Krenn PW; Zucchetto A; Gattei V; Greil R; Hartmann TN
    Br J Haematol; 2015 Apr; 169(2):286-9. PubMed ID: 25322676
    [No Abstract]   [Full Text] [Related]  

  • 48. Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia.
    Lu J; Cannizzaro E; Meier-Abt F; Scheinost S; Bruch PM; Giles HA; Lütge A; Hüllein J; Wagner L; Giacopelli B; Nadeu F; Delgado J; Campo E; Mangolini M; Ringshausen I; Böttcher M; Mougiakakos D; Jacobs A; Bodenmiller B; Dietrich S; Oakes CC; Zenz T; Huber W
    Nat Cancer; 2021 Aug; 2(8):853-864. PubMed ID: 34423310
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Variants of
    Božić T; Frobel J; Raic A; Ticconi F; Kuo CC; Heilmann-Heimbach S; Goecke TW; Zenke M; Jost E; Costa IG; Wagner W
    Life Sci Alliance; 2018 Dec; 1(6):e201800153. PubMed ID: 30582132
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aberrant Promoter Hypomethylation in CLL: Does It Matter for Disease Development?
    Upchurch GM; Haney SL; Opavsky R
    Front Oncol; 2016; 6():182. PubMed ID: 27563627
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loss of Dnmt3a induces CLL and PTCL with distinct methylomes and transcriptomes in mice.
    Haney SL; Upchurch GM; Opavska J; Klinkebiel D; Appiah AK; Smith LM; Heavican TB; Iqbal J; Joshi S; Opavsky R
    Sci Rep; 2016 Sep; 6():34222. PubMed ID: 27677595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape.
    Lu C; Jain SU; Hoelper D; Bechet D; Molden RC; Ran L; Murphy D; Venneti S; Hameed M; Pawel BR; Wunder JS; Dickson BC; Lundgren SM; Jani KS; De Jay N; Papillon-Cavanagh S; Andrulis IL; Sawyer SL; Grynspan D; Turcotte RE; Nadaf J; Fahiminiyah S; Muir TW; Majewski J; Thompson CB; Chi P; Garcia BA; Allis CD; Jabado N; Lewis PW
    Science; 2016 May; 352(6287):844-9. PubMed ID: 27174990
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic lymphocytic leukemia cells diversify and differentiate in vivo via a nonclassical Th1-dependent, Bcl-6-deficient process.
    Patten PE; Ferrer G; Chen SS; Simone R; Marsilio S; Yan XJ; Gitto Z; Yuan C; Kolitz JE; Barrientos J; Allen SL; Rai KR; MacCarthy T; Chu CC; Chiorazzi N
    JCI Insight; 2016 Apr; 1(4):. PubMed ID: 27158669
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IL-4 rescues surface IgM expression in chronic lymphocytic leukemia.
    Guo B; Zhang L; Chiorazzi N; Rothstein TL
    Blood; 2016 Jul; 128(4):553-62. PubMed ID: 27226435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape.
    Hamieh M; Dobrin A; Cabriolu A; van der Stegen SJC; Giavridis T; Mansilla-Soto J; Eyquem J; Zhao Z; Whitlock BM; Miele MM; Li Z; Cunanan KM; Huse M; Hendrickson RC; Wang X; Rivière I; Sadelain M
    Nature; 2019 Apr; 568(7750):112-116. PubMed ID: 30918399
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single-nucleotide human disease mutation inactivates a blood-regenerative GATA2 enhancer.
    Soukup AA; Zheng Y; Mehta C; Wu J; Liu P; Cao M; Hofmann I; Zhou Y; Zhang J; Johnson KD; Choi K; Keles S; Bresnick EH
    J Clin Invest; 2019 Mar; 129(3):1180-1192. PubMed ID: 30620726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AKR1C enzymes sustain therapy resistance in paediatric T-ALL.
    Bortolozzi R; Bresolin S; Rampazzo E; Paganin M; Maule F; Mariotto E; Boso D; Minuzzo S; Agnusdei V; Viola G; Te Kronnie G; Cazzaniga G; Basso G; Persano L
    Br J Cancer; 2018 Apr; 118(7):985-994. PubMed ID: 29515258
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genome-Wide Methylation Profiling of Peripheral T-Cell Lymphomas Identifies TRIP13 as a Critical Driver of Tumor Proliferation and Survival.
    Nowialis P; Tobon J; Lopusna K; Opavska J; Badar A; Chen D; Abdelghany R; Pozas G; Fingeret J; Noel E; Riva A; Fujiwara H; Ishov A; Opavsky R
    Epigenomes; 2024 Aug; 8(3):. PubMed ID: 39189258
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genome-wide methylation profiling of Peripheral T-cell lymphomas identifies TRIP13 as a critical driver of tumor proliferation and survival.
    Nowialis P; Tobon J; Lopusna K; Opavska J; Badar A; Chen D; Abdelghany R; Pozas G; Fingeret J; Noel E; Riva A; Fujiwara H; Opavsky R
    Res Sq; 2024 Feb; ():. PubMed ID: 38464090
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.